搜尋結果
2017年6月6日 · AstraZeneca, a leading global, science-led biopharmaceutical company, recently signed a multi-year agreement with ArisGlobal for LifeSphere Signal and Risk Management (formerly known as agBalance) to replace its current signal management platform.
The health of our planet directly impacts the health of humankind. ArisGlobal leads with a hands-on approach to sustainability by integrating environmental health, social equity, strategic governance, and economic vitality to create thriving, resilient communities for generations to come.
ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces an expansion to its C-suite.
China is aligning its regulatory environment with that of global standards with an aim to promote innovation, simplify drug development processes and to enhance the efficacy, quality and safety of the drugs approved. Read this whitepaper to learn how LifeSphere Safety MultiVigilance (ARISc), the drug safety software.
2020年12月7日 · MIAMI, FL December 7, 2020 – ArisGlobal, the leading provider of software that automates core product development functions for over 300 global life sciences companies, today announced several key executive hires as it continues to accelerate growth across its global markets.
Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection. MIAMI, FL April 22, 2020 – ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced Luye Pharma Group, an international ...